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Summary
Failure of distal nephrons to excrete excess acid results
in the “distal renal tubular acidoses” (dRTA). Early
childhood features of autosomal recessive dRTA in-
clude severe metabolic acidosis with inappropriately
alkaline urine, poor growth, rickets, and renal calci-
fication. Progressive bilateral sensorineural hearing
loss (SNHL) is evident in approximately one-third of
patients. We have recently identified mutations in
ATP6B1, encoding the B-subunit of the collecting-
duct apical proton pump, as a cause of recessive dRTA
with SNHL. We now report the results of genetic anal-
ysis of 13 kindreds with recessive dRTA and normal
hearing. Analysis of linkage and molecular exami-
nation of ATP6B1 indicated that mutation in ATP6B1
rarely, if ever, accounts for this phenotype, prompting
a genomewide linkage search for loci underlying this
trait. The results strongly supported linkage with lo-
cus heterogeneity to a segment of 7q33-34, yielding
a maximum multipoint LOD score of 8.84 with 68%
of kindreds linked. The LOD-3 support interval de-
fines a 14-cM region flanked by D7S500 and D7S688.
That 4 of these 13 kindreds do not support linkage
to rdRTA2 and ATP6B1 implies the existence of at
least one additional dRTA locus. These findings es-
tablish that genes causing recessive dRTA with normal
and impaired hearing are different, and they identify,
at 7q33-34, a new locus, rdRTA2, for recessive dRTA
with normal hearing.
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Introduction
In adult humans, the net result of catabolization of
an omnivorous diet is the production of a nonvolatile
acid load of ∼70 mmol H/d. To preserve acid-base
homeostasis, which maintains arterial pH very close
to 7.40, the kidney must excrete this acid. This func-
tion is critical for optimal activity of a wide variety
of physiological pathways.
The mechanism for urinary acidification is tightly
regulated in the distal part of the nephron (Alpern
and Rector 1996). In a process coupled to bicarbonate
reabsorption into the bloodstream, hydrogen ions are
secreted into the urine by specialized polarized a-in-
tercalated cells in the collecting duct (fig. 1). At the
apical surface of these cells, the main secretory com-
plex is the multisubunit proton pump (H-ATPase)
(Gluck 1992). In response to a drop in arterial pH,
this pump can increase urinary H concentration by
some 10,000 fold. At the basolateral surface of these
same cells, bicarbonate is reabsorbed, in exchange for
chloride, by the AE1 gene product. Proper a-inter-
calated cell function is important not only for main-
tenance of correct body-fluid pH but also for the sol-
ubility of calcium in urine and for the stability of
calcium in bone.
In type I, or distal, renal tubular acidosis (dRTA),
there is inadequate urinary H secretion by these a-
intercalated cells. The result of this defect (and a bi-
ochemical hallmark of dRTA) is that the urine is in-
appropriately alkaline (pH 15.5) in the presence of
metabolic acidosis, whether spontaneous or induced
by acid challenge (Lightwood 1935; Butler et al.
1936). In primary dRTA, metabolic acidosis of var-
ying severity is usually accompanied by hypokalemia
and hypercalciuria. If left untreated, the acidosis leads
to leaching of calcium and phosphate from bone, re-
sulting in osteomalacia, rickets, and growth impair-
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Figure 1 Urine acidification in the human collecting duct. A
schematic drawing of a nephron is shown (left). To achieve alterations
in urine H concentration of ≤10,000 fold, specialized a-intercalated
cells of the collecting duct (right) secrete H ions across their apical
surface via the multisubunit H-ATPase pump (ATP6). This molecule
comprises an ATP-catalytic “head” of 3A- and 3B1-subunits and a
membrane-anchored “stalk” of at least eight other subunits. H se-
cretion is coupled to absorption of HCO3
 across the basolateral sur-
face, by way of AE1, a 12–14-transmembrane-spanning Cl/HCO3

exchanger. Other transporters probably contribute to H and HCO3

transport in this cell type, but their significance in humans remains
unclear.
ment. Intrarenal deposition of calcium salts as stones
or nephrocalcinosis commonly occurs. Simple alkali
replacement suffices to correct the systemic metabolic
defects, but it does not appear to reverse nephrocal-
cinosis (McSherry and Morris 1978).
Inherited dRTA may be autosomal dominant (MIM
179800), in which case the disease is usually mild, or
autosomal recessive (MIM 267300 and MIM
602722), for which severe early presentation is the
rule. Among patients with recessive dRTA, a substan-
tial fraction have progressive and irreversible bilateral
sensorineural hearing loss (SNHL) (Zakzouk et al.
1995). Mutations in AE1 are responsible for domi-
nant dRTA in all kindreds thus far reported (Bruce et
al. 1997; Jarolim et al. 1998; Karet et al. 1998), but
recessive dRTA is rarely the result of mutations in this
gene (Karet et al. 1998; Tanphaichitr et al. 1998).
Recently, recessive dRTA with SNHL has been shown
to be caused by mutations in ATP6B1, which encodes
the B-subunit of the a-intercalated cell’s apical proton
pump (Karet et al. 1999). Hearing loss seen in patients
with mutations in this gene can be attributed to the
loss of H secretion into endolymph by ATP6B1-con-
taining H-ATPase within the cochlea, which is re-
quired for maintenance of appropriate endolymph
pH.
It is presently unknown whether recessive dRTA with
normal hearing is also attributable to mutations in
ATP6B1. In this report, we show that dRTA with normal
hearing is not accounted for by mutation in ATP6B1,
and we identify linkage of this trait to a new locus,
rdRTA2, on chromosome 7q33-34.
Families, Material, and Methods
Classification of Families
Thirteen kindreds with autosomal recessive dRTA and
normal hearing were ascertained via affected index cases,
as previously reported (Karet et al. 1999). All individuals
were classified as being affected if they demonstrated
inappropriately alkaline urine in the presence of meta-
bolic acidosis but had otherwise normal renal function
and absence of secondary causes of dRTA. Inheritance
was prospectively ascribed as being recessive either when
affected offspring were the result of a consanguineous
union of unaffected parents or when the union of un-
related unaffected parents resulted in at least two af-
fected offspring. This interpretation is supported by the
observed high penetrance of dominant disease; moreo-
ver, almost all the patients in the current study were
diagnosed by age 2 years, which is typical of recessive
disease, in contrast with patients who have dominant
disease, which is usually diagnosed later in life. The re-
search protocol was approved by the Yale University
Human Investigation Committee.
Phenotypic Data
With the use of age-appropriate normal ranges for
each referring hospital, the biochemical data obtained
included measurement of serum sodium, potassium,
creatinine, calcium, phosphate, and magnesium; mea-
surement of arterial blood pH; and determination of
urinary calcium, pH, electrolytes, and protein. Hear-
ing status was determined by pure-tone audiometry
and/or by brain-stem auditory evoked responses. Re-
nal calcification was assessed by ultrasonography and/
or radiography.
Linkage Studies
Genomic DNA was prepared, by standard proce-
dures (Bell et al. 1981), from whole blood of study
members. Genotyping of a total of 270 polymorphic
loci spanning all autosomes, as well as those in in-
tervals suggestive of linkage and the previously de-
scribed ATP6B1 locus, was performed by PCR with
a customized set of primers, as described elsewhere
(Craig et al. 1998). PCR products were labeled either
by incorporation of a[32P]-dCTP or by fluorescent
end-labeling of oligonucleotide primers, with analysis
performed on an ABI 377 instrument equipped with
GENESCAN 2.1 and GENOTYPER 1.1.1 software
(Applied Biosystems). All genotypes were scored in-
dependently by two investigators blinded to affection
status. Marker order was obtained from databases at
the Whitehead Institute for Biomedical Research/MIT
Center for Genome Research, The Cooperative Hu-
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Table 1
Primer Sequences for SLC4A2 Screening by SSCP
PRIMER SEQUENCE
(5′r3′)
EXON Forward Reverse
1 gttgagttgggagaagttgg tacccgctcgctctggacttc
2 cagcgcagcctgcgcgtg ggacccttggccggagcac
3 ctctggcactgggaagggtgag ggcctcctgtaggatctcctc
4 ggacactgtgcctgccacag gccctgccgacattccctag
5 ctcctagggaatgtcggcag ctgctaggatagtgaggtgatg
6 gggaggaggccaggtttctc ctcactcctttgcccaccag
7 ctggtgggcaaaggagtgag gagattacagctggtctgagag
8 gctcgctccggctctgtac gtgggagaatttcctggggac
9 catcccatctcctgccactg caggtgggctgaagtgtcatc
10 gatgacacttcagcccacctg cttcctcagccctgccgccag
11 ctggcggcagggctgaggaag ctcaaggcctggccaccaag
12 gtcctgctgctctgctcttg ggatgggctccaggaagcag
13 cagccctcttctttgtgctctc gaggcagccctggccccag
14 gaggtgggcaagaggggctcgtg gtggccaggccctgggcag
15 gtctcctgccatcacctttg ggaggggcggctggagatg
16 catccccacccagagctcag cctggcccagctctcgcag
17 gtccagctgatggaggccgtg aaccccctcttggcctttaag
18 ggcaggactctgagcgctg cttaaggacaggctgggtttg
19 caccttaacccttgtccctac ctggggctctggcctctcac
20 ccagcctgggcctcagcag ggaatccactggaagggaaag
21 cggggccaactctttctcctg gaggcacaccccttccggtg
22 gcaggctagggaggaagctg cacagggaggcaagaggaac
23 cccttcttgaccgccacctc ggagggaggggcatgggag
man Linkage Center, and The Genome Database. Ho-
mozygosity mapping (Lander et al. 1987) and analysis
of linkage were performed by use of the GENE-
HUNTER program (Kruglyak et al. 1996) run on a
Sun SPARCstation. Regions suggestive of linkage were
refined by typing these and additional markers in all
available family members.
Since only nuclear families were genotyped, and given
the ethnic variation among kindreds, each marker locus
was specified as having four alleles of equal frequency,
approximating 75% heterozygosity. The actual average
heterozygosity observed for these markers was 83%.
Models of the trait locus specified recessive transmission,
allowing for locus heterogeneity, with a disease-gene fre-
quency of 1/500, 99% penetrance, and a 1% phenocopy
rate. No substantial differences in LOD scores were ob-
tained when these parameters were varied.
Locus heterogeneity and multilocus LOD scores were
calculated as described elsewhere (Ott 1991). The like-
lihood ratio LR(a,v1) for linkage either to the rdRTA2
locus (v1) or to another locus in each kindred is aLR(v1)
 (1-a), where a is the proportion of families linked to
v1. Multilocus likelihood ratios for linkage to rdRTA2
or ATP6B1 (v2) were calculated, in each kindred, as
aLR(v1)  (1-a)(LRv2). Multilocus likelihood ratios for
linkage to rdRTA2, to ATP6B1, or to a third, unknown
locus were calculated, in each kindred, as aLR(v1) 
bLR(v2)  g, where b and g represent the proportion of
families linked to ATP6B1 or to the unknown locus,
respectively. The posterior probability of linkage to
rdRTA2 versus linkage to additional unknown loci was
calculated, in each kindred, as aLR(v1)/[aLR(v1)(1-a)].
Candidate-Gene Analysis
SLC4A2 was identified as a potential candidate be-
cause of its prior localization to chromosome 7q. It was
further localized on the human genetic map by radiation-
hybrid mapping, with primers 4F and 4R (table 1) used
to amplify exon 4 of this gene by means of PCR and
with DNA of the 93 hybrid cell lines in the Genebridge-
4 radiation-hybrid panel (Research Genetics) used as a
template. Products were visualized on a 2% agarose gel.
Results were submitted to the Whitehead Institute for
Biomedical Research/MIT Center for Genome Research
Web site for analysis.
Primers lying within introns were designed from ge-
nomic SLC4A2 sequence (GenBank accession numbers
U76667–U76669, U62290) and were used separately to
amplify all 23 exons by PCR. Products were denatured
and were subjected to SSCP analysis under two different
nondenaturing conditions, as described elsewhere (Shi-
mkets et al. 1994). Primer sequences are listed in table
1. Identified variants were eluted from gel and were
reamplified by PCR, and the DNA sequence of both
strands was determined, by use of the dideoxy termi-
nation method, on an ABI 377 instrument. An analogous
protocol was used to both amplify and sequence all ex-
ons and exon-intron boundaries of ATP6B1 from the
genomic DNA of patient RTA28-1, as previously de-
scribed (Karet et al. 1999; see also the Results section
below).
Results
Recessive dRTA Kindreds with Normal Hearing
The kindreds enrolled in this linkage study comprised
13 apparently unrelated families with autosomal reces-
sive dRTA, in which the hearing of all affected individ-
uals is normal (table 2). Of these families, 10 were from
different parts of Turkey, 2 were from Saudi Arabia, and
1 originated in Pakistan. In all but one family, affected
individuals were the offspring of consanguineous union;
union was between first cousins in nine kindreds, be-
tween second cousins in two kindreds, and between third
cousins in the other kindred (fig. 2).
Clinical and biochemical data are summarized in table
2. All patients presented with dRTA in early childhood;
in 14 of the 17 living affected patients, the diagnosis
was made at2 years of age. All patients presented with
severe metabolic acidosis (mean arterial pH 7.18 
6), with accompanying urine pH 6.5 and hypo-0.0
kalemia; renal function was otherwise normal. All but
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Table 2
Clinical and Biochemical Features at Diagnosis of Index Patients with dRTA and Normal Hearing
FEATURES AT DIAGNOSIS OF INDEX PATIENTS WITH dRTA AND NORMAL HEARING
Clinical Data Biochemical Dataa
Patient Age Urine Ca2
PATIENT
(SEX), AGE AT
STUDY (YEARS) Origin
At
Diagnosis
At
Audiometry
(Years) Rickets?
Arterial
pH
Serum
HCO3

(mM)
Serum K
(mM)
Urine
pH mg/kg/d
mg/mg
Creatinine
4-1 (F), 5.5 Turkey 3 wk 4.5 No 7.10 5.5 2.4 8.0 6.6
5-1 (F), 9 Turkey 1 year 9 No 7.12 11.0 3.1 7.0 6.0
11-1 (M), 10 Turkey 5 years 9 Yes 7.20 12.0 1.6 7.5 20.0
14-1 (F), 22.5 Turkey 6 years 22 Yes 7.20 13.0 3.5 7.2 8.0
17-1b (F), 21 Pakistan 1 wk 4 Yes 7.25 12.0 2.7 7.6 .4
23-1 (M), 13 Turkey 3 mo 12 No 7.10 12.0 2.8 7.5 5.7
28-1 (F), 5 Turkey 14 mo 4 Yes 7.23 14.0 2.8 6.5 1.2
34-1 (M), 3 Turkey 8 mo 2.5 Yes 7.23 16.0 2.1 6.8 5.5
37-1 (F), 10 Turkey 3 mo 9 No 7.10 5.5 2.2 7.0 .1
49-1 (M), 12 Saudi Arabia 5 mo NAc No 7.21 14.0 2.8 7.5 1.3
62-1b (F), 7 Turkey 3 years 7 No 7.20 7.6 3.0 7.0 .3
63-1 (M), 2 Turkey 6 mo 1 Yes 7.10 6.1 2.1 7.0 3.1
75-1 (M), 12.5 Saudi Arabia 2 years 3 Yes 7.25 11.4 3.3 7.0 .7
Overall mean
 SEMd 7.18 .06 10.8 3.3 2.6 .5 7.2 .4
Mean  SEM
for ATP6B1
mutantse 7.20 .09 10.9 2.5 3.1 .7 7.3 .6
a Normal ranges for biochemical data are as follows: arterial pH, 7.36–7.44; serum HCO3
, 20–28 mM; serum K, 3.5–5.0 mM; urine pH,
!6.0 in the setting of metabolic acidosis; urine calcium, !4.0 mg/kg/d or .2 mg/mg creatinine.
b Kindred has additional living affected member(s).
c NA = not available.
d Mean  standard error of the mean (SEM) for this study.
e Mean  SEM for 19 index patients with ATP6B1 mutations (Karet et al. 1999).
two index patients had elevated urinary calcium, and
nephrocalcinosis was present in all at diagnosis. None
had hypomagnesemia. Rickets was documented in the
affected members of seven kindreds. All affected patients
have undergone pure-tone audiometric evaluation, au-
ditory evoked–response measurements, or both, with
normal results. In no case has delay in the development
of speech been reported.
Candidacy of ATP6B1
Other than the difference in hearing status, there were
no significant differences in severity of acidosis or bio-
chemical parameters between these 13 kindreds and
those previously reported to have mutations in ATP6B1
(Karet et al. 1999). To test whether mutations in
ATP6B1 might account for a significant fraction of these
cases with normal hearing, genotyping of the polymor-
phic loci tightly linked to this gene on chromosome 2p13
was performed in all available family members. Analysis
of the results yielded a maximum multipoint LOD score
(Zmax) of 21.1 at the ATP6B1 locus, with a model of
genetic homogeneity. With the use of models allowing
locus heterogeneity, the Zmax was .69, with an estimated
18% of kindreds having linkage at this locus (fig. 3A).
Additionally, all exons and intron-exon boundaries of
ATP6B1 have been screened by SSCP analysis done un-
der two different conditions in all 13 kindreds, with the
use of the same primers and conditions that identified
mutations in 91% of hearing-impaired, apparently
linked kindreds (Karet et al. 1999). No mutations al-
tering the encoded gene product were identified. Taken
together, these findings indicate that mutations in
ATP6B1 do not commonly cause dRTA with normal
hearing.
Linkage of Recessive dRTA with Normal Hearing to
7q33-34
These results indicated that mutations in at least one
gene other than ATP6B1 cause recessive dRTA with nor-
mal hearing. To map a further gene or genes, a ge-
nomewide screen was performed, as described in the
Families, Material, and Methods section. Analysis of the
results of the initial screen identified seven intervals, on
chromosomes 5–8, 16, and 18, with multipoint LOD
scores 11.
Further polymorphic markers were genotyped in each

Figure 2 Haplotypes across the rdRTA2 interval in kindreds with dRTA. Genotypes for polymorphic loci in their chromosomal order (left) are shown below the symbol for each available
subject, as described in the Families, Material, and Methods section. Approximate genetic distances between adjacent loci are indicated. Genotypes enclosed by boxes indicate the maximum intervals
across which affected patients are homozygous or concordant in consanguineous or outbred kindreds, respectively. LOD scores at Zmax for rdRTA2 in each kindred are indicated below the pedigree
numbers.
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Figure 3 Multipoint analysis of linkage in 13 kindreds with
recessive dRTA and normal hearing. The model of linkage allowed
for locus heterogeneity and was as specified in the Families, Material,
and Methods section. Multipoint LOD scores across intervals con-
taining (A) the ATP6B1 locus on chromosome 2p and (B) the newly
identified rdRTA2 locus on chromosome 7q are shown. The Zmax
achieved at ATP6B1 was 0.69, with . Analysis of linkage, com-a = .18
paring segregation of rdRTA2 with 16 linked marker loci, demon-
strated a Zmax of 8.84. Approximate genetic distances between loci are
shown infigure 2. Thick and thin bars indicate the LOD-1 and LOD-
3 support intervals, respectively, for the location of rdRTA2.
Table 3
Multipoint LOD Scores, for Individual Families, at Zmax Positions
for rdRTA2 or ATP6B1
LOD SCORE
RTA
KINDRED
THEORETICAL
Zmax
At
rdRTA2
At
ATP6B1
POSTERIOR
PROBABILITYa
17 2.4 2.4 8.38 1.00
23 1.92 1.59 .84 .99
37 1.92 1.87 .84 .99
4 1.2 1.19 1.59 .97
49 1.2 1.19 1.64 .97
63 1.2 1.19 1.77 .97
34 1.2 1.18 .98 .97
5 1.2 .89 1.17 .94
62 .6 .6 4.79 .89
28 1.2 1.56 1.19 .06
14 1.2 1.55 1.2 .06
11 1.12 1.63 1.5 .05
75 2.64 1.91 1.91 .03
a rdRTA2 vs. unknown.
of these intervals, resulting in the being reduced to !1
in all but one interval, a segment of chromosome 7q33-
34, which had yielded the highest LOD score (3.90) in
the initial genomewide screen.
Genotypes at 16 marker loci in this segment of chro-
mosome 7 are displayed infigure 2. In eight consan-
guineous kindreds, segments of homozygosity were
observed across genetic distances 11 cM, incorpo-
rating at least seven consecutive homozygous loci in
each kindred. In addition, affected siblings in outbred
kindred RTA62 were concordant across 14 loci span-
ning 32 cM. All 16 loci across the 36-cM interval
flanked by loci D7S514 and D7S798 gave positive
LOD scores in pairwise analysis (data not shown).
With models of locus homogeneity, multipoint anal-
ysis of linkage resulted in a LOD score of 5.48 for link-
age of dRTA to this interval, with the Zmax lying in the
17-cM segment flanked by D7S500 and D7S688, ∼2
cM telomeric to D7S495. LOD scores for individual
kindreds at this Zmax are shown in table 3. It is apparent
that, although nine kindreds yielded LOD scores at or
near their theoretical maxima, four gave negative LOD
scores.
Further analysis allowing locus heterogeneity
yielded a Zmax of 8.84 for linkage to the interval be-
tween D7S495 and D7S684, with the Zmax lying in
approximately the same position and with an esti-
mated 68% of kindreds having linkage at this locus
(fig. 3B). This model is supported with odds 11,000
: 1 compared with the single-locus model, providing
significant evidence of linkage to 7q33-34, with locus
heterogeneity. Changing estimates of marker-allele
frequencies did not significantly alter the Zmax—for
example, when average marker heterozygosities were
specified as 90%, 67%, or 50%, LOD scores were
8.87, 8.79, and 8.24, respectively. These results iden-
tify, at 7q33-34, a locus for recessive dRTA with nor-
mal hearing, which we term “rdRTA2.” As shown in
figure 3B, the LOD-3 support interval for the location
of rdRTA2 spans ∼14 cM in the interval between loci
D7S509 and D7S688, whereas the LOD-1 support
interval includes some 11 cM between D7S495 and
D7S1798.
We tested whether some of the four families who do
not show linkage to rdRTA2 might, in fact, show linkage
to ATP6B1. LOD scores for linkage to ATP6B1 in each
kindred are shown in table 3. Only one of the kindreds
with negative LOD scores at rdRTA2 had a positive
LOD score at ATP6B1, indicating that linkage at these
two loci combined cannot account for all kindreds (the
multilocus LOD score of 6.78 was significantly lower
than that for linkage to rdRTA2 plus additional unspe-
cified loci). A further model, which allowed linkage to
rdRTA2, to ATP6B1, or to a third, unidentified locus,
gave a LOD score of 9.15, which was not significantly
greater than that seen for the model that does not include
linkage to ATP6B1. Finally, patient RTA28-1 represents
the only individual with a posteriori evidence of linkage
to ATP6B1 but not to rdRTA2 (table 3). Her genomic
DNA was, therefore, directly sequenced across all exons
and exon-intron boundaries of ATP6B1, to confirm the
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earlier negative SSCP results; no mutations were iden-
tified. Taken together, these findings do not support a
significant fraction of kindreds with recessive dRTA and
normal hearing that harbor mutations in ATP6B1.
Candidate-Gene Analysis
Screening of available databases showed that AE2,
a member of the chloride-bicarbonate–exchanger gene
family (SLC4A2 [MIM 109280]), has been localized
to the telomere of 7q (Palumbo et al. 1986). Because
of the known role of AE1 in dominant dRTA, AE2
was pursued as a candidate for rdRTA2. Radiation-
hybrid mapping placed this gene close to locus
D7S1798, at the telomeric border of the linked in-
terval. SSCP analysis of all 23 exons and exon-intron
boundaries in all 13 kindreds demonstrated only two
variants, both of which are single-base substitutions,
that alter the encoded protein. Gly471rGlu occurred
in patient RTA34-1 alone, whereas Gly29rGlu
proved to be a common variant, observed in kindreds
RTA17, 62, and 63 and in normal controls. Impor-
tantly, in two kindreds (RTA17 and RTA34) with long
segments of homozygosity in the rdRTA2 interval, the
variant was heterozygous in affected family members
and, moreover, was absent from patient RTA62-2.
This finding places SLC4A2 outside the linked interval
in these kindreds, and these results make it unlikely
that SLC4A2 is the rdRTA2 gene.
Discussion
The results of the genomewide linkage screen pre-
sented in this report identify a new locus, rdRTA2,
for autosomal recessive dRTA. Significantly, in con-
trast to patients with dRTA resulting from a mutation
in ATP6B1, all of these patients have normal hearing.
For models allowing locus heterogeneity, a Zmax of
8.84 provides strong support for the location of
rdRTA2 as being 7q33-34. Importantly, only approx-
imately two-thirds of this cohort of patients with
dRTA and normal hearing have findings supporting
linkage to this interval, indicating that recessive dRTA
with normal hearing is genetically heterogeneous.
With the exception of their hearing status, the kin-
dreds presented here do not appear to differ, either in
their presentation or in the biochemical severity of
their metabolic defect, from the cohort that we have
reported that harbors mutations in ATP6B1. This in-
dicates that, like ATP6B1, the rdRTA2-gene product
is required for normal distal nephron acid secretion.
However, in contrast to ATP6B1, these genetic data
indicate that rdRTA2 does not play an indispensable
role in inner-ear physiology.
In the assessment of the aberrant physiology charac-
teristic of dRTA, the sole mapped gene that constituted
a potential candidate for a primary role in acid-base
homeostasis was SLC4A2. The absence of disruptive se-
quence alterations and the observation of intragenic het-
erozygosity in some kindreds in which homozygous mu-
tations are expected effectively exclude SLC4A2 as being
the gene responsible for disease in this cohort. This find-
ing also refines the map location of SLC4A2 on chro-
mosome 7, suggesting a location telomeric to D7S1798.
Although no other candidate genes are currently
known to lie in the linked interval, the complex physi-
ology of the a-intercalated cell suggests a number of
possibilities for the identity of rdRTA2. First, rdRTA2
could, like ATP6B1, be part of the apical H-ATPase
complex itself. This ATPase contains at least 10 different
components (Stevens and Forgac 1997), not all of which
have yet been cloned and/or characterized. Importantly,
the B1-subunit isoform shows specificity for apical, as
opposed to the ubiquitous vacuolar, H-ATPases. In the
absence of more generalized clinical findings, we would
anticipate that, if rdRTA2 is an H-ATPase subunit, it
would also be specific for apical H-ATPases. Presently,
the B-subunit is the only one known to have an apical
pump–specific isoform (Nelson et al. 1992). However,
given the contrast in hearing between patients with mu-
tations in ATP6B1 and rdRTA2, the rdRTA2 gene prod-
uct would be unlikely to form part of the cochlear apical
H-ATPase. Alternatively, a defect in a gene whose prod-
uct is required for trafficking of the proton pump to the
apical membrane of the a-intercalated cell could also
result in defective proton-pump activity, without altering
any of the elements of the pump itself.
Third, defective H/K-ATPase function at the apical
surface of these cells has been proposed as a potential
mechanism of disease, consistent with the hypokalemia
seen in affected patients (Kurtzman 1990). However, the
observation that equally severe hypokalemia occurs, re-
gardless of whether patients harbor mutations in
ATP6B1 or in rdRTA2, indicates that hypokalemia in
dRTA does not require a defect in H/K-ATPase func-
tion. Moreover, the severity of acidosis in patients with
mutations in ATP6B1 implies that, in contrast to the
results of studies in animals (Silver et al. 1997), H/K-
ATPase activity cannot adequately compensate for di-
minished H-pump function, which suggests that this
pathway plays a lesser role in pH homeostasis in
humans.
Finally, defects in genes whose products are more in-
directly required for H secretion could result in the
observed phenotype; these defects include those in mech-
anisms in a-intercalated cells necessary for generation
of protons, absorption of bicarbonate, recycling of chlo-
ride, and maintenance of the electrochemical gradient
across both apical and basolateral membranes. Identi-
fication of the rdRTA2 gene will likely provide new in-
1664 Am. J. Hum. Genet. 65:1656–1665, 1999
sight into the fundamental physiology of pH homeosta-
sis in humans.
Our results will now direct further studies to narrow
the linked interval, to permit identification of this gene.
Since many of the kindreds reported here were recruited
from Turkey, we have sought a possible founder effect,
by examination of the original genotypes and haplotypes
in the rdRTA2 interval in this group. However, no evi-
dence of linkage disequilibrium is present in the current
data set, indicating either the absence of a founder effect
or a founder more remote than that which can be de-
tected by use of polymorphic microsatellite markers at
the current density (data not shown).
Linkage to rdRTA2 was not apparent in four families,
and we found no evidence supporting mutation in
ATP6B1 in this group. These findings strongly suggest
the existence of one or more additional loci in which
mutation can produce the dRTA phenotype. Although
the phenotypes of affected individuals from the four un-
linked kindreds do not differ substantially from those
linked to rdRTA2 (table 2), the index patients do show
a trend of greater urinary calcium loss, and all four have
had rickets. It is possible that the aberrant gene or genes
in these patients will exert a more seriously disruptive
effect on calcium metabolism. However, separate anal-
ysis of the genomewide linkage data in these four kin-
dreds alone has not yet provided significant evidence for
linkage to an additional locus, and further studies, in-
corporating new kindreds, may be necessary to confer
adequate power to detect additional dRTA loci. It was
also notable that no positive LOD scores were obtained
in the chromosome 17 interval containing AE1, thereby
providing no support for a role of this gene in recessive
dRTA, in contrast to its role in dominant disease (Karet
et al. 1998).
Taken together, these results provide significant evi-
dence that, in patients with recessive dRTA and normal
hearing, the phenotype is attributable to rdRTA2 and at
least one additional locus and that these loci are different
from the previously identified locus for recessive dRTA
with hearing impairment. Meanwhile, the studies re-
ported here provide a first step toward identification of
the underlying disease genes.
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